Sotera Health (NASDAQ:SHC) Price Target Raised to $20.00

Sotera Health (NASDAQ:SHC) had its target price lifted by Citigroup from $18.00 to $20.00 in a report issued on Wednesday,Benzinga reports. They currently have a buy rating on the stock.

SHC has been the topic of several other research reports. Barclays upped their price target on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research note on Tuesday, August 6th. Royal Bank of Canada reiterated an “outperform” rating and set a $17.00 price target on shares of Sotera Health in a research report on Tuesday, August 6th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.50.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $16.09 on Wednesday. The stock has a market capitalization of $4.56 billion, a price-to-earnings ratio of 64.36 and a beta of 2.08. Sotera Health has a 52 week low of $10.71 and a 52 week high of $17.44. The firm has a 50-day simple moving average of $15.98 and a 200-day simple moving average of $13.74. The company has a quick ratio of 2.59, a current ratio of 2.88 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company had revenue of $285.47 million during the quarter, compared to analyst estimates of $278.64 million. During the same period in the prior year, the business posted $0.18 EPS. Sotera Health’s revenue for the quarter was up 8.5% compared to the same quarter last year. On average, equities analysts predict that Sotera Health will post 0.64 earnings per share for the current fiscal year.

Insider Buying and Selling at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction on Friday, September 6th. The shares were sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the sale, the director now directly owns 49,215,301 shares in the company, valued at $739,705,974.03. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 55.12% of the stock is currently owned by insiders.

Institutional Trading of Sotera Health

Institutional investors and hedge funds have recently bought and sold shares of the business. State of Alaska Department of Revenue grew its holdings in shares of Sotera Health by 20.6% during the first quarter. State of Alaska Department of Revenue now owns 13,490 shares of the company’s stock worth $162,000 after buying an additional 2,300 shares during the last quarter. Mutual of America Capital Management LLC increased its holdings in shares of Sotera Health by 21.2% in the first quarter. Mutual of America Capital Management LLC now owns 74,086 shares of the company’s stock valued at $890,000 after purchasing an additional 12,939 shares during the period. Texas Permanent School Fund Corp raised its stake in shares of Sotera Health by 28.5% during the first quarter. Texas Permanent School Fund Corp now owns 108,545 shares of the company’s stock worth $1,304,000 after purchasing an additional 24,047 shares during the last quarter. Duality Advisers LP lifted its holdings in shares of Sotera Health by 74.9% during the first quarter. Duality Advisers LP now owns 29,019 shares of the company’s stock worth $349,000 after purchasing an additional 12,430 shares during the period. Finally, Swiss National Bank grew its position in Sotera Health by 0.5% in the 1st quarter. Swiss National Bank now owns 195,900 shares of the company’s stock valued at $2,353,000 after buying an additional 1,000 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.